Development of growth factor fusion proteins for cell‐triggered drug delivery
- 20 March 2001
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 15 (7) , 1300-1302
- https://doi.org/10.1096/fj.00-0564fje
Abstract
No abstract availableFunding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31-52261 NFP 38)
This publication has 21 references indexed in Scilit:
- Development of fibrin derivatives for controlled release of heparin-binding growth factorsJournal of Controlled Release, 2000
- Incorporation of heparin‐binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineeringThe FASEB Journal, 1999
- Local administration of neurotrophic growth factor in subcutaneous silicon chambers enhances the regeneration of the sensory component of the rat sciatic nerveMicrosurgery, 1999
- Cross-Linking Exogenous Bifunctional Peptides into Fibrin Gels with Factor XIIIaBioconjugate Chemistry, 1998
- Nerve Growth Factor in CNS RepairJournal of Neurotrauma, 1994
- Nerve growth factor enhances regeneration through silicone chambersExperimental Neurology, 1989
- Pharmacological effects of nerve growth factor and fibroblast growth factor applied to the transectioned sciatic nerve on neuron death in adult rat dorsal root gangliaNeuroscience Letters, 1987
- Human β-nerve growth factor gene sequence highly homologous to that of mouseNature, 1983
- Factor XIII‐mediated cross‐linking of NH2‐terminal peptide of α2‐plasmin inhibitor to fibrinFEBS Letters, 1983
- Amino acid sequence studies on the α chain of human fibrinogen. Location of four plasmin attack points and a covalent cross-linking siteBiochemistry, 1975